MA40908B1 - Anticorps anti-il-6 améliorés - Google Patents

Anticorps anti-il-6 améliorés

Info

Publication number
MA40908B1
MA40908B1 MA40908A MA40908A MA40908B1 MA 40908 B1 MA40908 B1 MA 40908B1 MA 40908 A MA40908 A MA 40908A MA 40908 A MA40908 A MA 40908A MA 40908 B1 MA40908 B1 MA 40908B1
Authority
MA
Morocco
Prior art keywords
antibodies
improved anti
relates
treatment
macular edema
Prior art date
Application number
MA40908A
Other languages
English (en)
Inventor
Michael March Schmidt
Alison Tisdale
Eric Furfine
Grigorios Zarbis-Papastoitsis
Original Assignee
Sesen Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sesen Bio Inc filed Critical Sesen Bio Inc
Priority claimed from PCT/US2015/059532 external-priority patent/WO2016073890A1/fr
Publication of MA40908B1 publication Critical patent/MA40908B1/fr

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des anticorps anti-il-6 améliorés. L'invention concerne des utilisations des anticorps dans le traitement de maladies associées à il -6, par exemple, des maladies oculaires telles que l'œdème maculaire diabétique.
MA40908A 2014-11-07 2015-11-06 Anticorps anti-il-6 améliorés MA40908B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462077105P 2014-11-07 2014-11-07
PCT/US2015/059532 WO2016073890A1 (fr) 2014-11-07 2015-11-06 Anticorps anti-il-6 améliorés

Publications (1)

Publication Number Publication Date
MA40908B1 true MA40908B1 (fr) 2019-11-29

Family

ID=69155916

Family Applications (1)

Application Number Title Priority Date Filing Date
MA40908A MA40908B1 (fr) 2014-11-07 2015-11-06 Anticorps anti-il-6 améliorés

Country Status (1)

Country Link
MA (1) MA40908B1 (fr)

Similar Documents

Publication Publication Date Title
MA42471B1 (fr) Compositions comprenant des souches bactériennes
MA44322A (fr) Compositions comprenant des souches bactériennes
MA41060A (fr) Compositions comprenant des souches bactériennes
MA55434B1 (fr) Compositions comprenant des souches bactériennes
EA201890285A1 (ru) Антитела против pd-1, активируемые антитела против pd-1 и способы их применения
MA41010A (fr) Compositions comprenant des souches bactériennes
CR20170060A (es) Anticuerpos anti tigit
EA201990043A1 (ru) Антибактериальные соединения
EA201992546A1 (ru) Средства на основе антител к cd33
MX2021008663A (es) Anticuerpos mejorados contra il-6.
EA201792616A1 (ru) Средства, пути применения и способы лечения синуклеопатии
EA201890453A1 (ru) Анти-angptl8 антитела и их применение
EA201790377A1 (ru) Антитела к глюкагону и их применения
CO2017008455A2 (es) Anticuerpos contra tau
TR201901886T4 (tr) DNA-PK inhibitörleri.
EA201692109A1 (ru) Варианты антител к фактору d и их применение
EA201890747A1 (ru) Способы лечения воспалительных заболеваний
FR3021970B1 (fr) Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
EA201791711A1 (ru) Антитела к транстиретину
EA201791710A1 (ru) Антитела к транстиретину
BR112018008900A2 (pt) composições compreendendo anticorpos para il6r para o tratamento de uveíte e edema macular e métodos de uso das mesmas
UY36262A (es) Anticuerpos anti proteína similar a angiopoyetina 4 y métodos de uso
EA201692402A1 (ru) Лекарственные формы для местного применения и их использование
FR3019465B1 (fr) Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen
MA39228A1 (fr) Compositions à utiliser pour le traitement d'états allergiques